HK1217199A1 - 促進幹細胞分化為肝細胞的化合物 - Google Patents

促進幹細胞分化為肝細胞的化合物

Info

Publication number
HK1217199A1
HK1217199A1 HK16105247.2A HK16105247A HK1217199A1 HK 1217199 A1 HK1217199 A1 HK 1217199A1 HK 16105247 A HK16105247 A HK 16105247A HK 1217199 A1 HK1217199 A1 HK 1217199A1
Authority
HK
Hong Kong
Prior art keywords
hepatocytes
compounds
stem cell
cell differentiation
improved stem
Prior art date
Application number
HK16105247.2A
Other languages
English (en)
Inventor
Eric Chiao
Matthew Michael Hamilton
Sei Kameoka
Brian Leonard
Miriam Triyatni
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of HK1217199A1 publication Critical patent/HK1217199A1/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/067Hepatocytes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/46Amines, e.g. putrescine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00Use of cells in diagnostics
    • C12N2503/02Drug screening
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/45Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HK16105247.2A 2013-03-15 2016-05-09 促進幹細胞分化為肝細胞的化合物 HK1217199A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361792019P 2013-03-15 2013-03-15
US201361811155P 2013-05-22 2013-05-22
PCT/EP2014/054763 WO2014140058A1 (en) 2013-03-15 2014-03-12 Compounds for improved stem cell differentiation into hepatocytes

Publications (1)

Publication Number Publication Date
HK1217199A1 true HK1217199A1 (zh) 2016-12-30

Family

ID=50272618

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16105247.2A HK1217199A1 (zh) 2013-03-15 2016-05-09 促進幹細胞分化為肝細胞的化合物

Country Status (11)

Country Link
US (2) US9334480B2 (zh)
EP (1) EP2970178B1 (zh)
JP (1) JP6129360B2 (zh)
KR (1) KR101767802B1 (zh)
CN (1) CN105051023B (zh)
BR (1) BR112015023185A2 (zh)
CA (1) CA2900690A1 (zh)
HK (1) HK1217199A1 (zh)
MX (1) MX346497B (zh)
RU (1) RU2662954C2 (zh)
WO (1) WO2014140058A1 (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3720441A1 (en) 2017-12-04 2020-10-14 H. Hoffnabb-La Roche Ag Pyrrolo[2,3-b]pyrazine compounds as cccdna inhibitors for the treatment of hepatitis b virus (hbv) infection
AU2021235252A1 (en) 2020-03-11 2022-10-06 Bit Bio Limited Method of generating hepatic cells

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7498171B2 (en) * 2002-04-12 2009-03-03 Anthrogenesis Corporation Modulation of stem and progenitor cell differentiation, assays, and uses thereof
EP1669441A1 (en) * 2003-08-27 2006-06-14 Renomedix Institute Inc. Method of differentiating mesenchymal stem cell into liver cell and artificial human liver cell
WO2007136300A2 (fr) * 2006-05-23 2007-11-29 Alla Chem, Llc Indoles substitués et procédé de production et d'utilisation de ceux-ci
JP6008297B2 (ja) * 2011-04-15 2016-10-19 国立大学法人鳥取大学 ヒト間葉系幹細胞を肝細胞へ分化誘導する新規化合物の合成と解析

Also Published As

Publication number Publication date
EP2970178A1 (en) 2016-01-20
WO2014140058A1 (en) 2014-09-18
JP6129360B2 (ja) 2017-05-17
CN105051023A (zh) 2015-11-11
JP2016511276A (ja) 2016-04-14
KR20150119342A (ko) 2015-10-23
KR101767802B1 (ko) 2017-08-11
MX346497B (es) 2017-03-22
US20150197726A1 (en) 2015-07-16
EP2970178B1 (en) 2017-06-14
RU2662954C2 (ru) 2018-07-31
MX2015011505A (es) 2016-01-22
US20150158840A1 (en) 2015-06-11
US9181218B2 (en) 2015-11-10
CN105051023B (zh) 2017-08-22
BR112015023185A2 (pt) 2017-07-18
CA2900690A1 (en) 2014-09-18
US9334480B2 (en) 2016-05-10
RU2015140469A (ru) 2017-04-21

Similar Documents

Publication Publication Date Title
IL246262A0 (en) Cell culture media
HK1223553A1 (zh) 細胞
IL241627B (en) A method for t-cell activation
EP2997133C0 (en) METHODS FOR PRODUCING, BY GENETIC ENGINEERING, A HIGHLY ACTIVE T-CELL FOR IMMUNOTHERAPEUTIC USE
HK1216761A1 (zh) 用於神經細胞培養的培養基組合物
PL2758523T3 (pl) Zrębowe komórki macierzyste
GB201318126D0 (en) Neuronal Stem Cell Differentiation
HK1221250A1 (zh) 用於培養細胞的結構件
IL245392A0 (en) A method for cell culture
HK1222886A1 (zh) 哺乳動物肌源性幹細胞
GB201420277D0 (en) Cell culture system
SG11201509767UA (en) Medium for culturing stem cells
GB201310031D0 (en) Cell
EP2978839A4 (en) CELL CULTURE METHOD
GB201303101D0 (en) Media for stem cells
HK1217199A1 (zh) 促進幹細胞分化為肝細胞的化合物
SG11201507338PA (en) Method for culturing cells
GB201310354D0 (en) Method for cell differentiation
GB201308905D0 (en) Cell culture
GB201306488D0 (en) Cell culture
GB201320573D0 (en) T Cell
GB201317589D0 (en) Cell
GB201307708D0 (en) Method for cell enrichment

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20230310